Navigation Links
Magellan to Receive Frost & Sullivan 2009 North American Product Innovation Award; Three-Minute LeadCare(R) II Test Identifies Children with Lead Poisoning
Date:3/17/2009

CHELMSFORD, Mass., March 17 /PRNewswire/ -- Magellan Biosciences, an emerging leader in systems for clinical-diagnostics, will receive the Frost & Sullivan 2009 North American Product Innovation Award for LeadCare II, a rapid, point-of-care test that enables children and adults to be screened for lead poisoning faster, easier, and more conveniently. Magellan's President of Clinical Diagnostics, James Whelan, will accept the award tomorrow night at the 2009 Excellence in Medical Technologies & Life Sciences Award Banquet in San Francisco, California.

"We are honored to receive this prestigious award, which recognizes both the technical advances required in achieving CLIA-waived status for LeadCare II, and the value of the point-of-care test in meeting a critical healthcare need," said Jim Whelan. "While there has been some encouraging news about U.S. progress in reducing lead poisoning -- this crisis is by no means over. Lead contamination remains a serious problem, and current send-out and prescription-based lead testing practices are missing the children most at risk for lead poisoning. While thankfully they are few and far between, we do get reports of isolated cases, often associated with home reconstruction, where a screening test during a routine check-up identifies a child with seriously high blood-lead levels. We had one as recently as last week. The good news is that in this case, as in all the others, the elevated results triggered an immediate and comprehensive response to attend to the child's health needs and identify and remediate the source of exposure. Unfortunately, despite its proven success in improving health outcomes, across the nation there are still barriers to widespread use of LeadCare II -- from the lack of Medicaid reimbursement to outdated regulations. We continue to work with local, state, and federal officials to ensure that all children have access to the point-of-care test."

Today, there
'/>"/>

SOURCE Magellan Biosciences
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
2. Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
3. Prometheus Receives New York State Approval for PROMETHEUS(R) IBS Diagnostic, First Blood Test for Irritable Bowel Syndrome
4. Catilin Receives Renewable Energy Award for Pilot Plant
5. Avon Protection Systems Receives NIOSH Approval for ST53 SCBA System
6. S*BIO Receives BioSpectrum Editors Choice, Emerging BioScience Company of Singapore Award
7. 3SBio Inc. Receives Official Recognition as a High-Tech Enterprise
8. AMPAC Fine Chemicals Receives the California Pollution Prevention Challenge Award Two Consecutive Years
9. Sinovac Receives GMP Certification for its New Filling and Packaging Production Facility
10. Advanced Life Sciences Receives Notice of Planned Cethromycin Review by FDA Advisory Committee
11. Serica Technologies Receives FDA 510(k) Clearance for SeriScaffold(TM) Technology for Soft Tissue Repair
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... December 23, 2014 Pipette.com announces their ... Twitter followers can submit their #HolidayInTheLab pictures for a ... lab mates. , For those struggling to think of ... Pipette.com Holiday in the Lab Contest provides the ideal ... followers to send pictures of their chemistree, holiday ...
(Date:12/24/2014)... LONDON , December 23, 2014 ... Review Algeria , out today and available for free ... the actors driving change and growth in the sector today. ... has scored notable successes has been in developing a homegrown ... 70 percent local production still remains some way off. A ...
(Date:12/24/2014)... YORK , Dec. 23, 2014  NeuroLifeSciences announced ... mazindol in children with attention deficit/hyperactivity disorder published in ... . The paper, titled "Pilot Phase ... disorder" ( Konofal et al, Drug Des ... ) shows that mazindol might be an effective, ...
(Date:12/22/2014)... VANCOUVER , Dec. 22, 2014 /PRNewswire/ - RepliCel ... stage regenerative medicine company focused on the development of ... paper out of the University of Calgary in conjunction ... North Carolina, which further validates the company,s ongoing clinical ... the effects of pattern baldness. The paper ...
Breaking Biology Technology:Major Pipette Distributor Pipette.com Announces their Holiday in the Lab Contest 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5
... Canopus,BioPharma, Inc. (OTC: CBIA), has confirmed the ... reducing agent and has also demonstrated the,synergistic effect ... and,cetuximab (Erbitux) in two mice lung cancer models., ... stated, "We at,Canopus are encouraged with the discovery ...
... Dominica, June 19 Neuftec,Limited, the proprietor of ... recently issued a claim against Oxonica Energy,Limited, a ... of its,European Patent in the High Court of ... AGM Statement issued by Dr Matthews,(CEO) on 19 ...
... biopharmaceutical industry information on ... ... BioSpace, the world,s,leading online community for the bioscience industry, released ... devices industries in Asia. AsiaBio(TM) features dynamic,informational Hotbed Web pages ...
Cached Biology Technology:CB1400, Patented by Canopus BioPharma, Prevents Tumor Growth and Enhances the Anti-Tumor Effects of Cisplatin and Cetuximab (Erbitux). 2Neuftec Responds to a Fundamental Inaccuracy in Oxonica PLC's Regulatory Announcement 2BioSpace Announces New Online Community for Asia 2
(Date:12/10/2014)... WINSTON-SALEM, N.C. , Dec. 9, 2014  Wake Forest ... medical education building for its School of Medicine. Funding ... a larger capital campaign that will be publicly launched ... will be located in the former 60 series R.J. ... Forest Innovation Quarter. Construction will begin immediately with plans ...
(Date:12/5/2014)... VIEW, Calif. , Dec. 4, 2014 /PRNewswire/ ... safety has boosted investments in new testing and ... has also given rise to a range of ... by the requirements of Generation Y, which is ... technologies. As a result, product development strategies of ...
(Date:12/3/2014)... GLENDALE, Ariz. , Dec. 2, 2014 ... biometric hand readers, Inception Technologies is pleased to announce ... it easier for customers to collect the workforce data ... the problems that have been left by existing readers. ... to user interface, connectivity and modern technology. Older models ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Inception Technologies to Release New Biometric Reader 2
... the regulation of blood stem cells and the complex, ... published in the February issue of Developmental Cell expands ... the role of a key gene known to be ... research will be useful for future studies aimed at ...
... team using a novel genetic cloning and sequencing technique has ... Midwest therapy pool, pointing to the need for closer scrutiny ... by Washington University in St. Louis and involving the University ... new study assessed the microbe population in a warm hospital ...
... studying how external information gets transmitted from outside of ... particular responses. But cell signaling networks are so complex ... , Now, a research team from Stanford, MIT and ... signaling networks quickly and accurately. Their findings appear in ...
Cached Biology News:New insight into regulation of blood stem cells 2New lab technique identifies high levels of pathogens in therapy pool 2New lab technique identifies high levels of pathogens in therapy pool 3Computational Method Speeds Mapping of Cell Signaling Networks 2Computational Method Speeds Mapping of Cell Signaling Networks 3